We will never make medicine affordable if how to tie a drug’s price to its value is solely determined by the companies creating the drugs.
The Earnings Boom Is Heavily Reliant on Just a Handful of Stocks
A handful of technology leaders are powering much of the expected growth in US corporate earnings. Explore why that concentration matters, what AI spending could mean for future profits, and which market signals investors may want to watch.
0 Comments